Mauritius-based private equity firm Adenia Partners has acquired a majority stake in Egypt’s Parkville Pharmaceuticals, marking its first controlling investment in the country.
The deal, subject to regulatory approvals, will see Adenia join forces with Parkville’s co-founders and executives, Chairman Sherif Bassiouny and CEO Mahmoud Farrag, to drive growth in the health and personal care sector.
Parkville, founded in 2008, has established itself as a significant player in Egypt’s pharmaceutical, cosmeceutical, and nutraceutical markets.
The company’s product range includes skincare, haircare, deodorants, and therapeutic pharmaceuticals, serving both mass and specialized markets.
With Adenia’s backing, Parkville plans to expand its product offerings, strengthen its digital presence, and explore regional markets across the Middle East and Africa.
Adenia’s investment aligns with its strategy of supporting established African businesses with growth potential. Managing Partner Stéphane Bacquaert said the firm is excited to partner with Parkville, citing the company’s focus on affordable, high-quality products as a key driver of growth.
Principal Heba Hakky added that the deal reflects confidence in Egypt’s economic fundamentals and the strength of local management teams.
The acquisition is Adenia’s latest move in its mission to drive growth and investment across Africa. With over $1 billion in capital managed across five funds, Adenia has established itself as a leading private equity player on the continent.
